A Description of Acute Renal Failure and Nephrolithiasis Associated With Sodium–Glucose Co-Transporter 2 Inhibitor Use: A VigiBase Study

A Description of Acute Renal Failure and Nephrolithiasis Associated With Sodium–Glucose Co-Transporter 2 Inhibitor Use: A VigiBase Study

Background: The Food and Drug Administration issued a warning on the risk of acute kidney injury and a signal of nephrolithiasis for patients using sodium–glucose co-transporter 2 inhibitors (SGLT2i). We performed a descriptive analysis on acute renal failure (ARF) and nephrolithiasis cases reported...

Full description

Bibliographic Details
Main Authors: Ioana Frent, Daniel Leucuta, Camelia Bucsa, Andreea Farcas, Florin Casoinic, Cristina Mogosan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pharmacology
Subjects:
SGLT2I
acute kidney injury
acute renal failure
nephrolithiasis
drug-induced acute kidney injury
drug-induced nephrolithiasis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.925805/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.925805/full

Similar Items